COMMUNIQUÉS West-GlobeNewswire

AVITA Medical to Announce Second Quarter 2026 Financial Results
14/07/2026
VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, [...]
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
14/07/2026
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year [...]
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
14/07/2026
Addressing the Radoff-JEC Group’s Misleading Claims Urges Stockholders to Vote “FOR” Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“ [...]
ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
14/07/2026
Initiated Himalayas-1 global Phase 3 trial in patients with mCRPC previously treated with abiraterone Entered into a clinical trial collaboration and supply agreement with Bayer to provide darolutamide for Himalayas-1 [...]
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
14/07/2026
SAN JOSE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in [...]
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
14/07/2026
FREMONT, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will report [...]
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
14/07/2026
Findings published in Neurology® show improvements in upper-limb motor function, activities of daily living, and quality of life were sustained for at least two years AUSTIN, Texas, July 14, 2026 (GLOBE NEWSWIRE) -- [...]
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14/07/2026
FOSTER CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a stock option to [...]
DBV Technologies présente ses résultats financiers du premier semestre 2026 et fait le point sur ses activités le 16 julliet 2026
14/07/2026
Châtillon, France, le 14 juillet (22:30 CEST) 2026 DBV Technologies présente ses résultats financiers du premier semestre 2026 et fait le point sur ses activités le 16 julliet 2026 DBV La Société organise une conférence [...]
DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
14/07/2026
Châtillon, France, July 14, 2026 DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026 Company to host investor conference call and webcast at 5:00 p.m. ET DBV [...]
La Plata County continues to improve code revisions
14/07/2026
Commissioners adopted five Land Use Code amendments that shave weeks off permitting timelines and launched a Proposition 123 “fast-track” for affordable housing — the latest steps in a code-reform effort the county [...]
Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
14/07/2026
REVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with palbociclib and [...]
Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
14/07/2026
Transaction positions the combined company to execute a capital-efficient, repeatable strategy leveraging public market access and Lōkahi Therapeutics ai²-driven asset sourcing, development, and advancement platform [...]
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
14/07/2026
BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market [...]
TAP Sleep Care Highlights Breakthrough Case Study on myTAP® Oral Appliance in Journal of Dental Sleep Medicine: Dramatic Two-Night Improvement in Treatment-Resistant OSA
14/07/2026
DALLAS, July 14, 2026 (GLOBE NEWSWIRE) -- TAP Sleep Care ® , a leader in innovative oral appliance therapy for snoring and obstructive sleep apnea (OSA), today announced the publication of a compelling case report [...]
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
14/07/2026
Real-World Findings Support Long-Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial Setting TOKYO and CAMBRIDGE, Mass., July 14, 2026 [...]
Arizona Nonprofit Launches "Ultimate Road Trip" Fundraiser Inspiring Families to Make Memories While Funding Childhood Blindness Research
14/07/2026
Winner will receive a 2026 Thor Axis motorhome, a Ford Bronco Badlands, and $50,000 cash in one of the charity's largest travel adventure prize packages ever. GILBERT, Ariz., July 14, 2026 (GLOBE NEWSWIRE) -- What if [...]
IBA – Information Réglementée
14/07/2026
Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et [...]
IBA – Regulated information
14/07/2026
July 14 th , 2026 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various [...]

Pages